Similar Items: The future of targeted therapies for pediatric central nervous system tumors
- Targeted therapies in adolescent and young adult patients with central nervous system tumors
- MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors
- From blunt tools to bullseyes: The impact of targeted therapy in pediatric neuro-oncology
- A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma
- Effects of physical exercise on central nervous system functions: a review of brain region specific adaptations
- FGFR alterations and potential role of FGFR inhibitors in pediatric brain tumors